Atla-Alternatives to Laboratory Animals

Papers
(The TQCC of Atla-Alternatives to Laboratory Animals is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Extension of the Virtual Cell Based Assay from a 2-D to a 3-D Cell Culture Model84
Spotlight on Three Rs Progress36
Spotlight on Three Rs Progress32
The Safety Assessment of Cosmetic Perfumes by Using In Chemico and In Vitro Methods in Combination with GC-MS/MS Analysis29
The Use of Human Tissues for Research: What Investigators Need to Know24
Conference Diary23
The Development of an Animal Product-free, Precision-cut Lung Slice Cryopreservation and Post-thaw Culture Method22
Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against Mycobacterium tuberculosis16
Combinatorial induction with valproic acid and fibroblast growth factor-9 enhances neural differentiation and cell fate commitment in adipose tissue-derived mesenchymal stem cells15
Conference Diary11
A History of the Development of Alternatives to Animals in Research and Testing11
Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA11
Brazilian National Network of Alternative Methods (RENAMA) 10th Anniversary: Meeting of the Associated Laboratories, May 202210
Editorial9
Dr Manfred Liebsch: Former Head of ZEBET and ATLA Editorial Board Member9
Development of Sensitive In Vitro Protocols for the Biocompatibility Testing of Medical Devices and Pharmaceuticals Intended for Contact with the Eyes: Acute Irritation and Phototoxicity Assess9
Resources Round-up9
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders9
In Silico Prediction of Human Clinical Pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an Established Benchmarking Data Set, a Modern Small Drug Data Set, and a Comparison with La8
The Rise of Three Rs Centres and Platforms in Europe*8
Spotlight on Three Rs Progress7
The 19th FRAME Annual Lecture, November 2022: Safer Chemicals and Sustainable Innovation Will Be Achieved by Regulatory Use of Modern Safety Science, Not by More Animal Testing7
Editorial7
2021 Michael Balls Award7
Resources Round-up7
Editorial7
Addressing Animal Welfare Issues in Fetal Blood Collection for Fetal Bovine Serum Production6
Fenugreek Seed Extract Regulates Human Umbilical Vein Endothelial Cell Angiogenesis and Proliferation via the PI3K/Akt/Cyclin D1 Pathway6
Thanks to Reviewers5
Reviewing Current Guidance for the ‘R’ of Replacement and Rethinking it with the ‘Replacement Checklist’5
The Numbers of Animals Used in Mexico for Scientific and Educational Purposes4
Editorial4
Corrigendum to Case Studies Exemplifying the Transition to Animal Component-Free Cell Culture4
Editorial4
Editorial4
Resources Round-up4
Development of Two Korean IACUC Guidance Documents to Foster Implementation of the Three Rs4
Editorial4
Optimisation of a Method for the Differentiation of Human Umbilical Cord-derived Mesenchymal Stem Cells Toward Renal Epithelial-like Cells4
A Cytotoxicity Assay as an Alternative to the Murine Model for the Potency Testing of Bothrops jararaca Venom and Antivenom: An Intralaboratory Pre-validation Study4
Accelerating Animal Replacement: How Universities Can Lead — Results of a One-Day Expert Workshop in Zurich, Switzerland3
Case Studies Exemplifying the Transition to Animal Component-free Cell Culture3
Editorial3
Spotlight on Three Rs Progress3
Spotlight on Three Rs Progress3
Editorial3
Conference Diary3
A New ATLA Associate Editor3
Editorial3
JRC Summer School 20213
Editorial3
Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 20212
The Use of 3-D Models of Echocardiographic Imaging Planes for Teaching Echocardiography Techniques for Use in Dogs and Cats2
Spotlight on Three Rs Progress2
Use of the Allium cepa Model to Assess the Cytogenotoxicity of Luffariella herdmani Marine Sponge Extract2
Transparency in Non-Technical Project Summaries to Promote the Three Rs in Respiratory Disease Research2
Lessons for the Future of NAMs from History, Philosophy and Social Studies of Science2
The Current Status and Work of Three Rs Centres and Platforms in Europe*2
ATLA Best Poster Award2
Editorial2
Journeying Through Journals: The Publishing Process and How to Maximise Research Impact2
The Application of New Approach Methodologies in Respiratory Disease Research: Their Role in Improving Translational Medicine from Bench to Bedside2
Determining the pathogenicity of uropathogenic Escherichia coli strains in the Galleria mellonella larvae model2
Introducing the COST Action ‘Improving the Quality of Biomedical Science with 3Rs Concepts’ (IMPROVE)2
Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids2
An Evaluation of the Replacement of Animal-derived Biomaterials in Human Primary Cell Culture2
Resources Round-up2
0.12647795677185